Abscess
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- An inflammatory process characterized by the accumulation of pus within a newly formed tissue cavity which is the result of a bacterial, fungal, or parasitic infection or the presence of a foreign body.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Abscess
- Therapeutic area
- Infectious Disease
- abscess
- abscess (disease)
- Abscess, Intra-Abdominal
- Disease mechanisms
- Acquired
Sources for recorded values
- All therapeutic areas
- Infectious Disease
Sources for recorded values
- Severity
- Mild
- MONDO ID
- MONDO:0005227
- Parent condition
- MONDO:0005550
Related records
Broader conditions (5)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
Narrower conditions (11)
- Breast abscess
- Corneal abscess
- Epidural abscess
- Intersphincteric abscess
- Intracranial abscess
- Liver abscess (disease)
- Lung abscess
- Peritonsillar abscess
- Pyoureter
- Splenic abscess
- Vitreous abscess
Trials (170)
- A Comparison of Techniques for Treating Skin Abscesses
- A Complicated Skin and Soft-tissue Infection Patient Registry
- A Non-Traumatic Binder for Temporary Abdominal Wall Closure
- A Perianal Abscess Cavity Packing vs no Packing.
- A Prospective Study of The Complement Depletion in Patients With Severe Abdominal Sepsis
- A Randomized Blinded Trial of Abscess Management With Packing vs No Packing
- A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
- A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
- A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
- A Study for Patients With Complicated Skin and Skin Structure Infections
- A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
- A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care
- Abces After Incision: Recurrence or Not?
- Abdominal aBscess Catheter Sclerotherapy (ABCS)
- Adjunctive Nitrous Oxide During ED Incision and Drainage of Abscess
- Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults
- Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses
- An Attempt to Reduce Community-Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection in Soldiers
- An Observational Study of Risk Factors and Long-term Prognosis of Patients With Liver Abscess in the "Real-world"
- Antibiotic Irrigations for Intra-Abdominal Drains
Approved drugs (1)
Drugs in development (23)
- Alteplase Phase 3
- Chlorhexidine gluconate Phase 2
- Clindamycin Phase 2
- CO-trimoxazole Phase 2
- Dalbavancin Phase 3
- Doxycycline Phase 2
- Fentanyl Phase 3
- Fentanyl hydrochloride Phase 3
- Linezolid Phase 3
- Methylene blue Phase 2
- Metronidazole Phase 3
- Morphine Phase 3
- Moxifloxacin Phase 3
- Oritavancin diphosphate Phase 3
- Piperacillin Phase 3
- Sodium chloride Phase 3
- Sulfamethoxazole Phase 3
- Tazobactam Phase 3
- Trimethoprim Phase 3
- Trimethoprim hydrochloride Phase 2